Reducing short-acting beta-agonist overprescribing in asthma: lessons from a quality-improvement prescribing project in East London

BACKGROUND: Excess prescription and use of short-acting beta-agonist (SABA) inhalers is associated with poor asthma control and increased risk of hospital admission. AIM: To quantify the prevalence and identify the predictors of SABA overprescribing. DESIGN AND SETTING: A cross-sectional study using...

Descripción completa

Detalles Bibliográficos
Autores principales: De Simoni, Anna, Hajmohammadi, Hajar, Pfeffer, Paul, Cole, Jim, Griffiths, Chris, Hull, Sally A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423045/
https://www.ncbi.nlm.nih.gov/pubmed/35995577
http://dx.doi.org/10.3399/BJGP.2021.0725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423045/
https://www.ncbi.nlm.nih.gov/pubmed/35995577
http://dx.doi.org/10.3399/BJGP.2021.0725

Ejemplares similares